NIAID Funding News, July 3, 2024

July 3, 2024 NIAID Funding News Read this full edition online at https://www.niaid.nih.gov/grants-contracts/funding-news?edition=2024-07-03 Feature Articles  Looking to the Future at the June Meeting of NIAID's Advisory Council NIAID Director Dr. Jeanne Marrazzo shared remarks before NIAID's Advisory Council, as did Dr. Steven Holland, Director of NIAID's Division of Intramural Research. Opportunities and Resources Call for Effective Data Reuse in Health Research Demonstrate innovative approaches to data reuse, explore strategies for leveraging data across data resources, and identify methods to ensure effective integration of data obtained through secondary analysis. Explore Mechanisms of Adverse Health Effects After Toxic Chemical Exposure Conduct fundamental research to characterize the acute or long-term pathophysiological effects of toxic chemical exposure on the pulmonary, ocular, or neurological system. In The News June's ACD Meeting—Outlining Plans to Pursue Major Priorities NIH's Advisory Committee to the Director (ACD) provides recommendations on program development, resource allocation, NIH administrative regulation, and other aspects of NIH policy. Provide Input for RFI on Public Engagement in NIH-Supported Clinical Research Through a new request for information (RFI), NIH seeks input on engaging the public throughout all stages of clinical research; not solely during recruitment or participation in clinical research and trials. News Briefs and Worth Repeating NIAID Strives to End the Use of Stigmatizing Language Contract Vendors Can Submit Inclusion Data Directly into HSS Nominate a Researcher for 2024 SGM Research Awards Program Advice Corner Contacting a Grants Management Specialist—For What and How? As an applicant or a funded investigator, there's a good chance you'll need guidance on administrative or budget matters related to your grant or cooperative agreement. Reader Questions "Are CDC and FDA part of NIH?" "Are consultants considered senior/key personnel?" New Funding Opportunities 75N93024R00019, Evaluation and Testing Services (ETS) for Vaccines NOT-AI-24-050, Notice of Special Interest (NOSI): Epigenetic Modulation of HBV cccDNA and Integrated HBV DNA (iDNA): Implications for Epigenetic Treatment Strategies Against HBV in HIV/HBV Co-Infection NOT-AI-24-053, Notice of Special Interest (NOSI): Discovery and Development of Oral Small-molecule Direct-acting Antivirals Targeting Viruses of Pandemic Potential PAR-24-030, CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01, Clinical Trial Not Allowed) Find other announcements at NIAID Opportunities and Announcements. Send suggestions or comments to deaweb@niaid.nih.gov. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. Your subscription may be removed if you do not open our emails for a six-month period.  This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107